Egleton: Sleep disorders Flashcards
BDZ
Decrease sleep latency
Decrease number of awakenings
Increase awakening threashold
More Stage 2, Less Stage 3/4
Increase net sleep time
ADR: Tolerance
Flurazepam
BDZ Little rebound effect Long half life (85hr) ADR: Sleepy during the day
Temazapam
BDZ Peak sedative 1-3 hr after oral dose Should be given 1-2 hours before bedtime
Triazolam
BDZ Induce sleep who are difficult falling asleep Short duration action Use intermittently Tolerance development
Zolouden
Work at BDZ receptors Quick onset Miminal rebound insomnia Less side effects Preserves sleep structure
Zaleplon
Work at BDZ receptor Rapid onset For broken sleep Rebound insomnia the first night, soon resolves Abuse potential
Eszopicione
BDZ like drug Longer half life than Zolpidem, Zaleplon Not restricted for short term use
Barbituates
Sedative hypnotics
ADR: tolerance, Coma at toxic dose, No antidotes
Decrease stage 3 and 4
Decrease # REM cycle and time in REM
Tolerance decelops to these effects
Depress neurogenic drive of respirataion
Minimal CVeffects at hypnotic doses
Activates delta-aminolevulinic acid synthetase
Contraindicated for porphyria
Don’t give to pregnant and breastfeeding mother
Barbituates: MoA
BDZ like
Open channels longer
Inhibit release of excitatory transmitters
At high dose, mimic GABA
Depress Ca currents and Ca dep neurotransmitter release
Stabilize membrane
BARBs: therapeutic use
Antagonize CNS stimulants
Anticonvulsants
Induce anesthesia: Thiopental
BARBs: tolerance
Tolerance to hyptonic effects of BARBS dose occur
Cross tolerance to other CNS depressants
Withdrawal reaction
BARB: analgesia
Hyperalgesia= more pain
Amobarbital, Pentobarbital, Thiopental
Trueth serum
IV admin
Sedation produce
Remove inhibition
BARB acute toxicity
Stupor/ coma
Respiratory depression
Circulatory collapse
Treatement:
Removeal of unabsorbed drug by lavage
Artifical ventilation
Hemodialysis
Charcoal
Abstitence syndrome
Chronic use downregulates GABA receptor
Increase cholinergic activity and elevates glutamate receptors
Potentially life threatening
Upon withdrawal intense cholinergic activity
Net effect= excitement
Treat
Hospitalization and stabilization with lowest dose that prevents syndrome